Ahmad SadrVICE-PRESIDENT OF TECHNICAL OPERATIONS
Ahmad joined Apellis as the VP of Technical Operations in 2017. Ahmad has an extensive record of accomplishments in developing diverse products from early to late stage commercial assets with such companies as Portola Pharmaceuticals, Vision Medicines, Genentech, and Wyeth. At Portola, Ahmad led critical aspects of outsourced Drug Substance manufacturing for Andexanet alpha. Mr. Sadr was the VP of Technical Operations at Vision Medicines, an ophthalmic biotech start-up with both small molecule and mAb drugs in development. At Genentech and Wyeth, Ahmad led teams in manufacturing science and technology, manufacturing collaborations, and supply chain with responsibility for global manufacturing of development and commercial stage biologics and pharmaceutical drugs. Ahmad holds a Management Certificate from Wharton, MS in Chemical Engineering from Widener University, and BS in Chemical Engineering from University of Maryland.